Cargando…

Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

CD4(+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacher, Petra, Rosati, Elisa, Esser, Daniela, Martini, Gabriela Rios, Saggau, Carina, Schiminsky, Esther, Dargvainiene, Justina, Schröder, Ina, Wieters, Imke, Khodamoradi, Yascha, Eberhardt, Fabian, Vehreschild, Maria J.G.T., Neb, Holger, Sonntagbauer, Michael, Conrad, Claudio, Tran, Florian, Rosenstiel, Philip, Markewitz, Robert, Wandinger, Klaus-Peter, Augustin, Max, Rybniker, Jan, Kochanek, Matthias, Leypoldt, Frank, Cornely, Oliver A., Koehler, Philipp, Franke, Andre, Scheffold, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689350/
https://www.ncbi.nlm.nih.gov/pubmed/33296686
http://dx.doi.org/10.1016/j.immuni.2020.11.016
_version_ 1783613848075370496
author Bacher, Petra
Rosati, Elisa
Esser, Daniela
Martini, Gabriela Rios
Saggau, Carina
Schiminsky, Esther
Dargvainiene, Justina
Schröder, Ina
Wieters, Imke
Khodamoradi, Yascha
Eberhardt, Fabian
Vehreschild, Maria J.G.T.
Neb, Holger
Sonntagbauer, Michael
Conrad, Claudio
Tran, Florian
Rosenstiel, Philip
Markewitz, Robert
Wandinger, Klaus-Peter
Augustin, Max
Rybniker, Jan
Kochanek, Matthias
Leypoldt, Frank
Cornely, Oliver A.
Koehler, Philipp
Franke, Andre
Scheffold, Alexander
author_facet Bacher, Petra
Rosati, Elisa
Esser, Daniela
Martini, Gabriela Rios
Saggau, Carina
Schiminsky, Esther
Dargvainiene, Justina
Schröder, Ina
Wieters, Imke
Khodamoradi, Yascha
Eberhardt, Fabian
Vehreschild, Maria J.G.T.
Neb, Holger
Sonntagbauer, Michael
Conrad, Claudio
Tran, Florian
Rosenstiel, Philip
Markewitz, Robert
Wandinger, Klaus-Peter
Augustin, Max
Rybniker, Jan
Kochanek, Matthias
Leypoldt, Frank
Cornely, Oliver A.
Koehler, Philipp
Franke, Andre
Scheffold, Alexander
author_sort Bacher, Petra
collection PubMed
description CD4(+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4(+) memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4(+) T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4(+) T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-7689350
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-76893502020-11-27 Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 Bacher, Petra Rosati, Elisa Esser, Daniela Martini, Gabriela Rios Saggau, Carina Schiminsky, Esther Dargvainiene, Justina Schröder, Ina Wieters, Imke Khodamoradi, Yascha Eberhardt, Fabian Vehreschild, Maria J.G.T. Neb, Holger Sonntagbauer, Michael Conrad, Claudio Tran, Florian Rosenstiel, Philip Markewitz, Robert Wandinger, Klaus-Peter Augustin, Max Rybniker, Jan Kochanek, Matthias Leypoldt, Frank Cornely, Oliver A. Koehler, Philipp Franke, Andre Scheffold, Alexander Immunity Article CD4(+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4(+) memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4(+) T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4(+) T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection. Elsevier Inc. 2020-12-15 2020-11-26 /pmc/articles/PMC7689350/ /pubmed/33296686 http://dx.doi.org/10.1016/j.immuni.2020.11.016 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bacher, Petra
Rosati, Elisa
Esser, Daniela
Martini, Gabriela Rios
Saggau, Carina
Schiminsky, Esther
Dargvainiene, Justina
Schröder, Ina
Wieters, Imke
Khodamoradi, Yascha
Eberhardt, Fabian
Vehreschild, Maria J.G.T.
Neb, Holger
Sonntagbauer, Michael
Conrad, Claudio
Tran, Florian
Rosenstiel, Philip
Markewitz, Robert
Wandinger, Klaus-Peter
Augustin, Max
Rybniker, Jan
Kochanek, Matthias
Leypoldt, Frank
Cornely, Oliver A.
Koehler, Philipp
Franke, Andre
Scheffold, Alexander
Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
title Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
title_full Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
title_fullStr Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
title_full_unstemmed Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
title_short Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
title_sort low-avidity cd4(+) t cell responses to sars-cov-2 in unexposed individuals and humans with severe covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689350/
https://www.ncbi.nlm.nih.gov/pubmed/33296686
http://dx.doi.org/10.1016/j.immuni.2020.11.016
work_keys_str_mv AT bacherpetra lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT rosatielisa lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT esserdaniela lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT martinigabrielarios lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT saggaucarina lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT schiminskyesther lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT dargvainienejustina lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT schroderina lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT wietersimke lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT khodamoradiyascha lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT eberhardtfabian lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT vehreschildmariajgt lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT nebholger lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT sonntagbauermichael lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT conradclaudio lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT tranflorian lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT rosenstielphilip lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT markewitzrobert lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT wandingerklauspeter lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT augustinmax lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT rybnikerjan lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT kochanekmatthias lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT leypoldtfrank lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT cornelyolivera lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT koehlerphilipp lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT frankeandre lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19
AT scheffoldalexander lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19